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Abstract
Studying astrocytes in higher brain functions has been hamperedBackground: 
by the lack of genetic tools for the efficient expression of inducible Cre
recombinase throughout the CNS, including the neocortex. Methods: 
Therefore, we generated BAC transgenic mice, in which CreERT2 is expressed
under control of the  regulatory region. When crossbred to CreAldh1l1 Results: 
reporter mice, adult Aldh1l1-CreERT2 mice show efficient gene targeting in
astrocytes. No such Cre-mediated recombination was detectable in CNS
neurons, oligodendrocytes, and microglia. As expected, Aldh1l1-CreERT2
expression was evident in several peripheral organs, including liver and kidney.
Taken together, Aldh1l1-CreERT2 mice are a useful tool forConclusions: 
studying astrocytes in neurovascular coupling, brain metabolism, synaptic
plasticity and other aspects of neuron-glia interactions.
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Introduction
Cre-mediated recombination of target genes in adult astrocytes 
requires the use of an inducible expression system, because many 
promoters of the astrocyte lineage are also active in multipoten-
tial neural stem cells in the subventricular and subgranular zones 
(Christie et al., 2013). Thus, transgenic mouse lines have been 
generated for tamoxifen-inducible Cre recombination of target 
genes in mature astrocytes (Chow et al., 2008; Ganat et al., 2006; 
Hirrlinger et al., 2006; Mori et al., 2006; Slezak et al., 2007). 
However, none of them achieves sufficient recombination to 
study the function of genes in the majority of cortical and spinal 
cord astrocytes.
The aldehyde dehydrogenase 1 family member L1 (Aldh1l1), also 
known as 10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6), 
converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2 
together with the reduction of NADP+ (Kutzbach & Stokstad, 
1971). The Aldh1l1 gene is expressed in a subset of radial glia 
in the midline of the embryonic CNS (Anthony & Heintz, 
2007) and neuronal precursors (Foo & Dougherty, 2013). By 
transcriptional profiling in postnatal brain, Aldh1l1 was identified 
to be specifically expressed in astrocytes (Cahoy et al., 2008), 
which increase Aldh1l1 expression about tenfold with maturation 
(Zhang et al., 2014). To date, Aldh1l1 is regarded a pan-astrocyte 
marker, as determined in BAC transgenic mice with a fluorescent 
reporter protein or constitutive Cre expression under control of 
the Aldh1l1 promoter (Heintz, 2004; Yang et al., 2011). There-
fore, we selected the Aldh1l1 regulatory region and a similar BAC 
transgenic strategy to target transgenic expression of CreERT2 to 
mature astrocytes.
Results and discussion
Efficiency of recombination in astrocytes of Aldh1l1-CreERT2 
transgenic mice
We generated Aldh1l1-CreERT2 transgenic mice by inserting 
a CreERT2 cassette (Sauer, 1994) under control of the Aldh1l1 
promoter in a murine BAC (BAC RP23-7M9). Targeting the first 
coding exon of Aldh1l1 by homologous recombination, we substi-
tuted the open reading frame of exon 2 with the CreERT2 cDNA 
(Figure 1a). Three lines of BAC transgenic mice were obtained 
by pronuclear injection, and crossbred with the Cre reporter mice 
ROSA26-Tdto or ROSA26-Eyfp (Madisen et al., 2010; Srinivas 
et al., 2001). Based on the degree of expression, one of the 
three lines of Aldh1l1-CreERT2 mice was selected for detailed 
characterization of double-transgenic offspring.
First, we determined the leakiness of reporter expression in adult 
Aldh1l1-CreERT2 mice. After corn oil injections in Aldh1l1-
CreERT2*ROSA26-Tdto mice, we found very few labeled cells 
(less than 5 per section), demonstrating that the inducible Cre 
system operates tightly. In parallel experiments, adult Aldh1l1-
CreERT2 mice were analyzed 7 days after tamoxifen induction. 
Sagittal brain sections revealed numerous tdTomato Cre reporter 
expressing cells, which in the forebrain exhibited the typical 
morphology of protoplasmic astrocytes (Figure 1). Co-labeling 
revealed that almost all S100beta (S100 calcium-binding protein B) 
positive cells in hippocampus and cerebral cortex expressed 
tdTomato (Figure 1, Table 1).
For comparison, when using a less sensitive EYFP Cre reporter line 
(Srinivas et al., 2001) in corresponding experiments, only two thirds 
of all S100beta positive cells in the cortex were also EYFP positive 
(Table 1). Thus, although both Cre reporter lines were generated as 
a knock-in into the endogenous ROSA26 locus, the recombination 
efficacy achieved is clearly different, in agreement with previous 
reports (Madisen et al., 2010; Srinivas et al., 2001). This finding 
illustrates the need to determine recombination efficiency individu-
ally for each combination of Cre allele and floxed target gene.
To characterize the identity of targeted cells functionally, we 
patched in total 18 tdTomato expressing cells in the cortex 
(Figure 1e). As expected, all cells displayed the electrophysi-
ological signature of mature astrocytes (Grass et al., 2004; 
Schipke et al., 2001), with low input resistance (20.79 ± 9.26 
mean MΩ ± sd; n=18) and negative resting membrane potential 
(-78.71 ± 3.22 mV).
The expression pattern of some astroglial marker proteins, such as 
GFAP (glial fibrillary acidic protein), differs between protoplas-
mic astrocytes in the cortex and fibrous astrocytes in white matter. 
We therefore assessed the efficacy of Cre recombination sepa-
rately for the corpus callosum, fimbria, hippocampus and spinal 
cord. Again, in all these regions a large majority of astrocytes, as 
defined by S100beta or GFAP, expressed Cre reporter, e.g. 85±1% 
in the corpus callosum and 94±2% in the fimbria (n=3 animals) 
(Figure 2, Table 1). Co-labeling with GFAP was not used for cell 
counts because of the protein’s low abundance in cell bodies which 
makes unequivocal quantification difficult.
In the cerebellum, a large fraction (89 ± 1%) of S100beta positive 
Bergman glia cells expressed the Cre reporter EYFP (Figure 2c, 
Table 1). While 3.3 ± 0.3% of parvalbumin positive interneurons 
of the molecular layer expressed the tdTomato Cre reporter, none 
was double positive in corresponding experiments using the EYFP 
Cre reporter, confirming the sensitivity of the tdTomato reporter 
with a tendency for off-target recombination. Cre reporter expres-
sion was also observed in some neurons in the dentate gyrus and 
olfactory bulb, likely reflecting some recombination in adult 
neural stem cells in the subgranular and subventricular zone, 
followed by the migration of labeled progeny through the rostral 
migratory stream (Figure 1c).
Next, we compared Aldh1l1-CreERT2 mediated recombination 
with the expression pattern of EGFP in Aldh1l1-Egfp transgenic 
mice, generated with a similar BAC based strategy (Heintz, 2004). 
As expected, reporter and EGFP expression was nearly identical 
in the cortex, confirming the high efficiency of CreERT2 mediated 
induction of the tdTomato reporter (Figure 3a).
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Figure 1. The Aldh1l1 BAC transgene efficiently targets CNS astrocytes. a) Scheme of the cloning strategy of Aldh1l1-CreERT2 BAC 
transgene. b) Immunoblot detecting RFP (tdTomato) in cortex (CTX), cerebellum (CB) and spinal cord (SC) lysates of two animals each, as 
indicated. GAPDH shows comparable loading of protein. c) Direct fluorescence of the Cre-reporter tdTomato in sagittal sections of Aldh1l1-
CreERT2*ROSA26-Tdto mice. d) Immunolabeling of the astrocyte marker S100beta in the cortex reveals almost complete overlap with the 
tdTomato Cre reporter in astrocytes. Scale, 20 µm. e) CCD camera image of a tdTomato positive astrocyte with the position of the patch 
pipette outlined as dashed lines (scale, 20 µm, left) that showed a typical passive response to the voltage step protocol (middle). The IV-curve 
of this cell is shown (right panel, open circles) together with the averaged IV curve of all 18 analyzed cells (mean ± sd).
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Table 1. Efficiency and specificity of Aldh1l1-CreERT2 mediated recombination in brain. Efficiency and 
specificity of inducible Cre mediated recombination in adult Aldh1l1-CreERT2 mice crossbred with Cre reporter 
ROSA26-Tdto or ROSA26-Eyfp. For each value shown (average percentage), cells were counted on eight confocal 
images and two sections for each of n=4 animals. Efficiency is expressed as percent Cre reporter positive cells 
of all S100beta labeled cells. Specificity is expressed as percentage of all Cre reporter positive cells that lack 
immuno-labeling for S100beta.
Region Marker Co-labelled cells (%) Number of analyzed cells
Efficiency 
     Cortex (astrocytes) tdTomato/S100beta 
EYFP/S100beta










89 ± 1 






     Cortex (astrocytes) S100beta neg./tdTomato S100beta neg./EYFP












Finally, in comparison with Slc1a3 (Glast)-CreERT2 (Mori et al., 
2006), Aldh1l1-CreERT2 mediated recombination of the tdTomato 
reporter revealed nearly complete recombination of astrocytes 
in spinal cord white matter, whereas Slc1a3-CreERT2 mediated 
fluorescence appeared patchy (Figure 3b).
Cellular specificity of Cre expression
Next, we tested the cell-type specificity of the Aldh1l1-CreERT2 
transgene. Co-localization of tdTomato with markers for neurons 
(NSE, neuron specific enolase) or microglia (Iba1, ionized cal-
cium binding adaptor molecule 1) was virtually absent (Figure 4, 
Table 2). However, we observed a small fraction of Cre reporter 
positive cells co-localizing with Olig2 (oligodendrocyte line-
age transcription factor 2), a transcription factor found in all 
oligodendrocyte lineage cells, including oligodendrocyte pre-
cursor cells (Figure 4b). Similarly, in triple transgenic mice that 
additionally express EYFP under control of the endogenous NG2 
(neural/glial antigen 2) promoter (Karram et al., 2008), we iden-
tified 3.4% of double labeled cells, presumably oligodendrocyte 
precursor cells based on their localization and morphology. 
However, co-localization with a marker of mature oligodendrocytes 
(CAII, carbonic anhydrase 2) was negligible 12d after tamoxifen 
injections, and did not increase in mice that were analyzed 27 weeks 
after recombination (tamoxifen induction at 16 weeks of age). This 
suggests that the small percentage of Aldh1l1-CreERT2 expressing 
NG2 glia does not give rise to oligodendrocytes. An independently 
generated line of Aldh1l1-CreERT2 mice (Srinivasan et al., 2016) 
shows some Olig1, Olig2, CNP and CAII but no NG2 expres-
sion, as determined by ribotag-dependent transcriptome profiling 
(Sanz et al., 2009). Whether this dissimilarity is caused by the 
different detection methods employed remains to be determined.
Cre recombination in peripheral organs
Aldh1l1 is an enzyme of folate metabolism that is expressed in 
various peripheral organs (Krupenko & Oleinik, 2002). In agree-
ment, we detected Cre reporter expression in liver, kidney, lung, 
and small intestine by direct immunofluorescence and Western 
blotting (Figure 5). Cre reporter was not detected in heart muscle.
Dataset 1. Raw data generated or analyzed during the present 
study in a zipped file
http://dx.doi.org/10.5256/f1000research.10509.d147854 
Conclusion
Aldh1l1 is a general marker for astrocytes within the CNS, and our 
new line of tamoxifen-inducible Aldh1l1-CreERT2 transgenic mice 
can be used to genetically target astrocytes in the mature CNS with 
high efficiency and specificity. When the corresponding genomic 
recombination in peripheral tissues is well tolerated, this line is 
suitable to study gene functions in astroglial cells of adult mice. 
Aldh1l1-CreERT2 mice will be made freely available upon request 
to the corresponding author.
Methods
Transgenic mice
All animal studies were performed at the Max Planck Institute of 
Experimental Medicine in compliance with the animal policies 
of the Max Planck Institute of Experimental Medicine and were 
approved by the German Federal State of Lower Saxony. All animals 
were housed in individually ventilated cages in groups of 3–5 mice 
per cage, kept in a room with controlled temperature (~23°C) under 
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Figure 2. Inducible targeting of Bergman glia and white matter astrocytes. Co-immunolabeling of the astrocyte marker S100beta or GFAP 
with Cre reporter (direct tdTomato fluorescence, GFP anti EYFP or RFP anti tdTomato) in fimbria (a), hippocampus (b), cerebellum (c) and 
spinal cord (d) reveals almost complete overlap of the transgene with astrocytes. Scale, 50 µm.
12 h light/dark cycle and had access to food and water ad libitum. In 
addition to the newly generated inducible Aldh1l1-CreERT2 mouse 
line (see below), we used BAC transgenic Aldh1l1-Egfp mice 
(Heintz, 2004), Slc1a3-CreERT2 mice (also called Glast-CreERT2; 
Mori et al., 2006), and NG2-EYFP knock-in mice (Karram et al., 
2008). As Cre reporter we used the ROSA26 flox-stop-flox-Tdto-
mato line (ROSA26-Tdto; Madisen et al., 2010) and the ROSA26 
flox-stop-flox-EYFP line (ROSA26-Yfp; Srinivas et al., 2001). We 
used a total of 26 mice of both sexes at the age of 7–10 weeks 
unless otherwise stated (20 – 30 g body weight). All mice were 
analyzed as heterozygotes for the respective transgenic allele.
Generation of Aldh1l1-CreERT2 mice
By PCR we introduced 50 bp of the Aldh1l1 intron 1/ exon 2 
sequence 5’ of the CreERT2 open reading frame. The bovine growth 
hormone poly A sequence (bGH pA), the frt (flippase recognition 
site) flanked kanamycin resistance cassette, and 50 bp of Aldh1l1 
genomic sequence was inserted into an Nhe1 site 3’ to the ERT2 
sequence. The combined construct was introduced into exon 2 of 
the Aldh1l1 gene on the BAC RP23-7M9 (BACPAC Resources of 
the Children’s Hospital Oakland Research Institute in Oakland), in 
frame with the start ATG, by homologous recombination in bacteria 
(EL250) as described (Lee et al., 2001). Excision of the resistance 
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Figure 3. Comparison with other transgenes targeting astrocytes. a) Co-immunolabeling of the Cre reporter tdTomato (anti RFP) and 
EGFP (anti GFP) in triple transgenic mice (Aldh1l1-CreERT2*ROSA26-Tdto*Aldh1l1-Egfp) in cortical sections. Scale 50 µm. b) Direct 
fluorescence of the Cre-reporter tdTomato in spinal sections of Aldh1l1-CreERT2*ROSA26-Tdto and Slc1a3-CreERT2*ROSA26-Tdto 
transgenes. Scale 50 µm.
cassette was done by arabinose induced flippase expression. The 
BAC insert was excised by Not I digestion and purified by size 
exclusion chromatography using a sepharose column. Pronucleus 
injection gave rise to 5 transgenic founder mice. Genotyping 
was done by PCR of purified tail genomic DNA under standard 
conditions with the primers (5’-3’, final concentration 0.25 µM) 
CAACTCAGTCACCCTGTGCTC and TTCTTGCGAACCTCAT-
CACTCG amplifying the 3’ part of intron1 of the Ald1l1 gene to 
the 5’ part of the Cre open reading frame. Three out of five founder 
mice that were crossed with reporter mice showed expression in 
brain. Only one line (Aldh1l1-CreERT2 line 02) showed robust 
expression in forebrain astrocytic cells and minimal expression in 
other cell types of the brain. 
Tamoxifen administration
Tamoxifen (Sigma, T5648) was dissolved in corn oil (Sigma, 
C8267) at a concentration of 7.5 mg/ml and injected intraperi-
toneally at 75 µg/g body weight on 5 consecutive days. We used 
a total of 26 mice of both sexes at the age of 7–10 weeks unless 
otherwise stated (20 – 30 g body weight). Mice were analyzed 12 
(immunohistochemistry) and 20 days (electrophysiology) after 
tamoxifen induction.
Immunostaining
After perfusion with 4% paraformaldehyde (w/v) in phosphate 
buffered saline (PBS, pH 7.4) for 20 min, tissue specimens were 
either cut on a vibratome (40 µm) or cryoprotected in 30% sucrose/
PBS, frozen and cut on a cryostat at -22°C (spinal cord 14 µm, 
peripheral organs 20 µm). Tissue sections were processed for 
immunohistochemistry by permeabilization in 0.4% Triton X-100 
(Sigma, T8787) in PBS for 30 min, blocking in 4% horse serum 
(HS) and 0.2% Triton X-100 in PBS for 30 min and incubation 
with first antibody in 1% HS and 0.05% Triton X-100 in PBS 
at 4°C overnight or for 48h (CAII and Olig2). Incubation with 
secondary antibodies and DAPI (4’,6-diamidino-2-phenylin-
dole) were in 1.5% HS in PBS for 2h at room temperature after 
which sections were mounted in AquaPolymount (Polysciences). 
Specimens were analyzed by epifluorescence microscopy using 
a Plan-Apochromat 20x/0.8 objective (Zeiss Axio Oberser.Z1 
with ApoTome.2) and the ZEN 2 software (Zeiss). Confocal laser 
scanning microscopy (Leica SP2 equipped with a HC PL APO 
lambda blue 20x/0.7 objective or with a Leica SP5 (HCX PL APO 
CS 20x/0.7, HCX PL APO lambda blue 40x/1.25, HCX PL APO 
CS 100x/1.44 objectives) using the Leica Confocal Software (Leica 
Microsystems). Images were processed with NIH ImageJ and 
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Figure 4. Specificity of Aldh1l1-CreERT2 mediated recombination. a) Direct fluorescence of the Cre-reporter tdTomato and 
immunolabeling of neurons (NSE) and microglia (Iba1) on cortical sections. Scale, 50 µm. b) Direct fluorescence of the Cre-reporter tdTomato 
and immunolabeling of mature oligodendrocytes (CAII, scale, 50 µm) and oligodendroglia (Olig2, scale, 20 µm). c) Co-immunolabeling of 
the Cre reporter tdTomato (anti RFP) and EYFP (anti GFP) in triple transgenic mice (Aldh1l1-CreERT2*ROSA26-Tdto*NG2-Eyfp) revealing 
co-labeling in a small fraction of cells. Scale, 20 µm.
Table 2. Specificity of Aldh1l1-CreERT2 mediated recombination 
in brain. Specificity of inducible Cre mediated recombination in 
adult Aldh1l1-CreERT2*ROSA26-Tdto mice. For each value (average 
percentage), cells were counted on eight confocal pictures and 
two sections for each of n=4 animals. Specificity is expressed as 
percentage of cells that show Cre reporter expression of all cell type 
marker positive cells.









0.4 ± 0.3 






Cerebellum tdTomato / Parvalbumin 3.3 ± 0.3 2504
*analyzed in triple transgenic mice (Aldh1l1-CreERT2*ROSA26-Tdto*NG2-Eyfp)
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Figure 5. Recombination in peripheral organs. a) Direct fluores-
cence of the Cre-reporter in transgenic Aldh1l1-CreERT2*ROSA26-
Tdto mice in liver, kidney, lung and intestine. Nuclei are shown in 
white (DAPI). Scale, 50 µm. b) Western blot detecting RFP (tdTomato) 
in lung, liver, kidney, small intestine, and heart, as indicated. GAPDH 
served as loading control.
Adobe Photoshop CS5.1 softwares. For quantification, cells were 
counted on eight confocal images for each of the n=4 animals.
Immunoblotting
Tissue was lysed in sucrose buffer containing 320 mM sucrose, 
10mM Tris-HCL (pH 7.4), 1mM NaHCO3, 1mM MgCl2, 1% 
Triton X-100, 2% lithiumdodecylsulfate, 0.5% sodiumdeoxycho-
late, and protease and phosphatase inhibitors (cOmplete™, PhosS-
TOP™, Roche). 25 µg (brain tissue) and 20 µg (lung, liver, kid-
ney, small intestine, heart) of protein lysates were resolved on 12% 
SDS-polyacrylamide gels under denaturing conditions and elec-
tro-transferred to PVDF membranes (Hybond P; GE Healthcare). 
Blocking was performed for 1h in Tris buffered saline / 0.05% 
Tween 20 (TBST) containing 5% milk powder and incubated 
in primary antibody at 4°C overnight in the same solution. 
Membranes were washed in TBST prior to incubation with appro-
priate horseradish peroxidase (HRP)-conjugated secondary anti-
bodies (1:5000 Dianova, Hamburg) for 1h. Blots were developed 
by enhanced chemiluminescence (Pierce, Rockford) and scanned 
using the ChemoCam Imager (Intas Science Imaging Instruments, 
Goettingen).
Antibodies
The following primary antibodies were used in this study: 
S100beta (rabbit monoclonal, 1:200, Abcam, ab52642), NSE 
(rabbit polyclonal, 1:500, Chemicon, AB951), CAII (polyclonal 
rabbit, 1:100, generous gift from S. Ghandour), GFAP (monoclonal 
mouse, 1:200, Chemicon, MAB3402), Parvalbumin (polyclonal 
rabbit, 1:1000, Swant, PV-28), Iba1 (rabbit polyclonal, 1:1000, 
Wako, 019-19741), Olig2 (polyclonal rabbit, 1:100, generous gift 
from Charles Stiles and John Alberta), RFP (polyclonal rabbit, 
1:500 (immunostaining) or 1:1500 (immunoblotting), Rockland, 
600-401-379), GAPDH (monoclonal mouse, 1:2500, Stress-
gen, CSA-335), and GFP (polyclonal goat, 1:500, Rockland, 
600-101-215). We used Alexa Fluor 488-conjugated (1:2000, Inv-
itrogen, A21206, 21202, A11055), Alexa Fluor 555-conjugated 
(1:2000, Invitrogen, A31572) and DyLight 633-conjugated (1:500, 
YO Proteins 356) secondary antibodies.
Electrophysiology
Acute forebrain slices from 8 weeks old Aldh1l1-CreERT2*ROSA26-
Tdto (n=3) mice were prepared as described previously (Schnell 
et al., 2015). Briefly, after deep isoflurane narcosis, animals were 
decapitated, the forebrain was prepared and placed in ice-cooled, 
carbogen-saturated (95 % O2, 5 % CO2) artificial cerebrospinal fluid 
(aCSF; in mM: 118 NaCl, 3 KCl, 1.5 CaCl2, 1 MgCl2, 1 NaH2PO4, 
25 NaHCO3, and 30 D-glucose; 330 mosmol/l, pH7.4). Sagittal sec-
tions (300 µm) were cut on a vibroslicer (VT1200 S, Leica) and 
stored in aCSF at (35–36°C) for at least 30 min. Subsequently, slices 
were transferred to the recording chamber and kept submerged by 
a platinum grid with nylon fibers for mechanical stabilization. The 
chamber was mounted on an upright microscope (Axioscope FS, 
Zeiss Germany, 40x objective) and continuously perfused with aCSF 
at room temperature at a flow rate of 5–10 ml/min. Astrocytes were 
identified by their red fluorescence in epifluorescence illumination 
(white-LED, Lumencor Sola SE II) using a tdTomato optimized 
filter set (excitation 560/40 nm; dichroic mirror 595 nm, emission 
645/75 nm; AHF Analysentechnik). For documentation, images of 
recorded tdTomato-expressing cells were taken with a CCD camera 
(Sensicam, PCO) and Imaging workbench 6.0 software (Indec Bio-
systems). Whole-cell voltage-clamp recordings were obtained with 
a MultiClamp 700B Amplifier (Molecular Devices). Patch elec-
trodes were pulled from borosilicate glass capillaries (Biomedical 
Instruments, Zülpich, Germany) using a horizontal pipette-puller 
(Zeitz-Instrumente, Germany). Electrodes were filled with (in mM) 
125 KCl, 1 CaCl2, 2 MgCl2, 4 Na2ATP, 10 EGTA, 10 HEPES (pH 
adjusted to 7.2 with KOH) leading to tip resistance of 2 – 6 MΩ. 
Currents were low-pass filtered at 3 kHz, and sampled at 10 kHz 
and recorded with pClamp 10 software (Molecular Devices) and 
stored for off-line analysis. Astrocytes were voltage-clamped to 
–80 mV and characterized by a voltage step protocol. Therefore, 
cells were hyperpolarized by -80 to -10 mV and depolarized by 
+10 mV to +110 mV voltage steps (10 mV increment).
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Data availability
Dataset 1: Raw data generated or analyzed during the present 
study in a zipped file. DOI, 10.5256/f1000research.10509.d147854 
(Winchenbach et al., 2016).
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The paper by Winchenbach . describes a newly generated astrocyte-specific Aldh1L1-CreERT2et al
mouse line resulting in Cre-mediated recombination after Tamoxifen injection.
This new mouse line addresses the crucial need in the field for a conditional line in which Cre is both
astrocyte-specific, and yet present in the absolute majority of astrocytes homogeneously throughout the
CNS. Prior models have reportedly suffered from either lower astrocyte specificity (such as certain
Glast-CreERT lines), or lower levels of astrocytic expression, with significant differences depending on
the brain area (such as in GFAP-CreERT2 lines). The authors commit to making their new mouse line
freely available on request.
On balance, the new Aldh1l1-CreERT2 mouse line from Nave/Saher, together with a similar line
independently generated and recently published by the Khakh lab  have a large potential to advance
astroglial research. Both labs have done a great service to the field by making their mice freely available.
Consequently, these are likely to be highly useful tools for generating and studying astrocyte-specific
knockouts and even knock-ins.
 
Detailed comments:
In this paper the authors used 5 Tamoxifen injections to induce recombination in Aldh1l1-CreERT2
animals crossbred with either Rosa-26-tdTomato or -YFP mice, and quantified the % recombination in
S100beta-positive cells (putative astrocytes) across different brain regions after 7 days by
immunohistochemistry. A subset of cells was additionally examined after 20 days by electrophysiology.
Other controls were also performed.
Co-staining with neuronal markers shows very limited overlap with neurons; recombination in a small (3%)
subset of parvalbumin-positive cells of the cerebellum is judged to be the artifact of the tdTomato reporter
line as it was absent in the YFP line. Neuronal expression in areas of adult neurogenesis is also reported,
similar to what was already observed in prior astrocyte lines. Peripheral organs were also examined, and
the authors report expected recombination in some of them.
The manuscript is technically sound and of high scientific quality. The paper provides a thorough
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Below we list some minor suggestions for improving the paper, as well as some general points applicable
for the entire field.
Issues to be addressed for Aldh1l1-CreERT2 mice:
The authors could add more information regarding image quantification (Tables 1 & 2). Do “eight
confocal pictures” mean single-plane images of different areas of the slice, or stacks? Of what
thickness? What was the zoom, axial/lateral resolution, field of view?
 
The authors provide a helpful electrophysiological confirmation of reporter-expressing cells as
passive astrocytes. As a very minor methodological point, they could indicate whether they used
liquid junction potential correction.
 
Definitive marker for “astrocytes.” Can the authors discuss why they think that S100Beta is the
best marker of astrocytes? This is relevant in particular for correctly interpreting the existing
 S100Beta-negative population as astrocytic or non-astrocytic: indeed, the authors report that
about 4-19% of S100Beta-negative cells also express reporters (Table 1). What are those cells?
 
Related to the previous point, the authors have performed GFAP co-staining but do not currently
report the % co-labelling due to difficulty in quantification. An image from spinal cord is shown in
Fig. 2d. However, some summary statement, even based on a limited number of manually
analyzed cells, would be helpful. Do they see some of the S100beta-negative (reporter-positive)
cells also positive for GFAP?
 
The authors report about 6% of cells double-label for markers of other cell types (e.g.
oligodendrocyte precursors or microglia) in Table 2. Do these account for the 4-19% of
S100Beta-negative/reporter-positive cells in Table 1? Importantly, neuronal co-labelling is reported
as nonexistent (with NSE) at least in the cortex. Is this the same also in other areas?
 
With the publication of the present line, there are now two Aldh1l1-CreERT2 mouse lines openly
available on the “market.” It remains for the field to determine which of the two lines has the most
reliable and therefore useful profile, meaning  highest astrocyte specificity as well as  highest
recombination efficiency in astrocytes. As the authors suggest, there may already be some
differences regarding expression in e.g. NG2 cells, to be determined in the follow-up studies.
 
Preserving a “reference” strain of mice (e.g. via frozen sperm) may be helpful to avoid gene drift
and future emergence of colonies with different properties. Ostensibly, this mechanism may
explain conflicting results historically reported for other “astrocytic” mice in the field such as
dnSNARE (see e.g. Fujita  J Neurosci 2014, reviewed in Bazargani and Attwell, Nat. et al.
Neurosci. 2016)
 
“Titration” curve for tamoxifen induction  One of the strengths of this mouse line is the very high.
recombination efficiency across diverse astrocyte populations: ~90% of likely astrocytes after just
five Tamoxifen injections. The authors emphasize the need to determine the % recombination for
each individual line. Additionally, it would be useful in the future to know how differences in
tamoxifen treatment regime correspond to different levels of recombination for some common lines
(e.g. Rosa26-tdTomato). For instance, is a single injection sufficient to cause recombination in the
bulk of astrocytes? Is it also possible to achieve sparser expression of the reporter (for single-cell
imaging studies) with a reduced Tamoxifen administration (e.g. single-day)? Can the %
recombination be raised over 90%, and if so, after how many injections? Obviously, the ultimate %
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recombination be raised over 90%, and if so, after how many injections? Obviously, the ultimate %
recombination will depend also on a chosen reporter line (as apparent from Table 1), but more
preliminary information for common lines would already be helpful.
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This manuscript by Winchenbach  described generation and characterization of a new transgenic toolet al
to investigate astrocyte biology.  The field is currently limited by cre recombinase driver transgenic
reagents that show poor coverage and/or temporal control during central nervous system development. 
The current paper uses ALDH1L1 cre ERT2 BAC transgenic mice to address limitations in the field,
developing a useful new tool.  The data presented are technically sound and included the use of crosses
with two conditional reporter alleles, single cell patch clamp electrophysiological analysis to confirm
astrocyte features and inclusionary and exclusionary immunohistochemistry.  The conclusions are
supported by data and also highlight the utility of this new transgenic allele, compared to a
commonly-used (GLAST-CRE) transgenic driver mouse, such that I think will be of significant interest in
this new mouse line from the glial biology community.
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Very nice piece of work! I'm sure the mouse line will be of great help for the community.
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Very nice piece of work! I'm sure the mouse line will be of great help for the community.
In case the authors prepare a revised version according to the reviewer's suggestions, I would like to add
my two pence and suggest that the authors specify which colour is used for each channel in the dual
colour images. The reader can only assume that, e.g., tdTomato is depicted in red and anti-S100B in
green. Giving the information in the figure legends will increase the understandability of the figures.
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